Akari Therapeutics Plc (AKTX)
0.3936
0.00 (0.00%)
USD |
NASDAQ |
Dec 15, 16:00
0.3936
0.00 (0.00%)
After-Hours: 19:09
Akari Therapeutics Research and Development Expense (TTM): 2.971M for Sept. 30, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| DBV Technologies SA | 95.77M |
| Cellectis SA | 70.72M |
| Biodexa Pharmaceuticals Plc | 6.352M |
| NuCana Plc | 15.52M |
| Autolus Therapeutics Plc | 112.76M |